NASDAQ:MSON Misonix (MSON) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free MSON Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$26.54▼$26.5450-Day Range$24.89▼$26.5452-Week Range$11.04▼$26.99Volume2 shsAverage Volume60,302 shsMarket Capitalization$462.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Misonix alerts: Email Address Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here About Misonix Stock (NASDAQ:MSON)Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.Read More Ad Crypto 101 MediaCrypto Market Preps For Trillions Worth of Inflows! Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.Click to join the Crypto Community Summit Free Online Event MSON Stock News HeadlinesMarch 29, 2024 | msn.comCrystal Mason’s voter fraud conviction overturnedMarch 28, 2024 | msn.comHow the Texans created $6.4 million in Shaq Mason's restructured contractMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 28, 2024 | msn.comMason's Matula, Purcell Marian's Mosley named OHSBCA Coaches of the YearMarch 28, 2024 | uk.news.yahoo.comPinsent Masons blazes a trail as finance goes digitalMarch 27, 2024 | msn.comPayne Education Center receives $225,000 grant for teacher training in literacy programsMarch 26, 2024 | uk.news.yahoo.comLocal masons from oldest Inverclyde institution hold Burns Club supperMarch 25, 2024 | msn.comCity of Jackson bringing new life to former Masonic Temple after more than a decade of vacancyMarch 29, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionMarch 23, 2024 | yahoo.comGoshen landmark now under new managementMarch 19, 2024 | msn.comNew steakhouse by well-known South Shore restaurateur to open in Quincy this fallMarch 11, 2024 | msn.comThree teens charged after transgender girl stabbed at roller-skating partyMarch 6, 2024 | msn.comMeet The Easter Bunny To Be Hosted At The Mason LodgeMarch 6, 2024 | msn.comITV Coronation Street fans rumble Mason's DNA link to Weatherfield after spotting clueMarch 5, 2024 | msn.comJessie Wallace's sister Danielle Mason claims her autistic son, 12, hasn't been to lessons for over a year because 'no mainstream school will take him'March 5, 2024 | msn.comPinsent Masons urges NI businesses to review cyber defencesMarch 4, 2024 | msn.comIreland's only female Freemason was a 'courageous woman' who blazed a trailMarch 3, 2024 | msn.comCoronation Street star Luca Toolan reveals Mason's secret backstoryMarch 1, 2024 | msn.comCoronation Street star Luca Toolan reveals Mason's reaction as Eliza crime is revisitedFebruary 28, 2024 | msn.comMason's Derek Badgley on hunt to reach top podium spot at MHSAA wrestling state finalsFebruary 27, 2024 | mirror.co.ukITV Coronation Street bully Mason's downfall sealed as secret second victim revealedFebruary 22, 2024 | msn.comElgin News Digest: Dark Matters Podcast fest at Side Street Studio Arts; South Elgin Father/son and mother/daughter events planned in April; Friends of Masons holding St ...February 22, 2024 | msn.comMason's 19 lead Rice past UAB 94-71February 22, 2024 | sfgate.comGEORGE MASON 71, NO. 16 DAYTON 67February 22, 2024 | msn.comGeorge Mason's free-throw shooting upends No. 16 DaytonFebruary 21, 2024 | msn.comHugh Dallas responds to 'crackpot' conspiracy theory claiming he’s a MasonFebruary 21, 2024 | msn.comNoname, Isata Kanneh-Mason among top Houston live events to see this weekSee More Headlines Receive MSON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Misonix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/02/2021Today3/28/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Laboratory Apparatus & Furniture Sub-IndustryN/A Current SymbolNASDAQ:MSON CUSIPN/A CIK880432 Webwww.misonix.com Phone(631) 694-9555Fax631-694-9412Employees254Year Founded1959Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,470,000.00 Net Margins-19.55% Pretax Margin-19.37% Return on Equity-10.36% Return on Assets-7.29% Debt Debt-to-Equity Ratio0.29 Current Ratio2.61 Quick Ratio1.92 Sales & Book Value Annual Sales$74.02 million Price / Sales6.24 Cash FlowN/A Price / Cash FlowN/A Book Value$7.77 per share Price / Book3.42Miscellaneous Outstanding Shares17,410,000Free Float11,893,000Market Cap$462.06 million OptionableNot Optionable Beta1.36 Social Links Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesStavros G. VizirgianakisChief Executive Officer & DirectorAllan R. StaleyPresidentSharon W. KlugewiczChief Operating OfficerJoseph P. DwyerChief Financial Officer, Secretary & TreasurerDaniel VoicVP-Engineering, Research & DevelopmentKey CompetitorsCS DiscoNYSE:LAWNETGEARNASDAQ:NTGRStoneridgeNYSE:SRIAviat NetworksNASDAQ:AVNWBandwidthNASDAQ:BANDView All Competitors MSON Stock Analysis - Frequently Asked Questions How were Misonix's earnings last quarter? Misonix, Inc. (NASDAQ:MSON) issued its quarterly earnings results on Thursday, September, 2nd. The medical equipment provider reported ($0.26) earnings per share for the quarter, missing analysts' consensus estimates of ($0.24) by $0.02. The medical equipment provider had revenue of $19.69 million for the quarter. Misonix had a negative trailing twelve-month return on equity of 10.36% and a negative net margin of 19.55%. What is Michael A. McManus Jr.'s approval rating as Misonix's CEO? 3 employees have rated Misonix Chief Executive Officer Michael A. McManus Jr. on Glassdoor.com. Michael A. McManus Jr. has an approval rating of 33% among the company's employees. This puts Michael A. McManus Jr. in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Misonix own? Based on aggregate information from My MarketBeat watchlists, some companies that other Misonix investors own include Edap Tms (EDAP), Varian Medical Systems (VAR), Sociedad Química y Minera de Chile (SQM), Avadel Pharmaceuticals (AVDL), Second Sight Medical Products (EYES), Aldeyra Therapeutics (ALDX), Ardelyx (ARDX) and Athenex (ATNX). This page (NASDAQ:MSON) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Misonix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.